American Century Companies’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

American Century Companies's THRX Position: Q1 2024 in Review

American Century Companies sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 10,514 shares — an estimated $42.6K sold.

American Century Companies first reported a position in THRX in Q3 2023 and held it in 2 quarters. The position peaked at $42.6K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

• American Century Companies reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
• American Century Companies sold 10,514 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $42.6K.
• American Century Companies first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
• American Century Companies's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $42.6K in Q4 2023.
• 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.